Advertisement
Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
As of 09:57AM EDT. Market open.
| Previous Close | 6.65 |
| Open | 6.67 |
| Bid | 6.63 x 300 |
| Ask | 6.78 x 100 |
| Day's Range | 6.62 - 6.78 |
| 52 Week Range | 4.71 - 10.24 |
| Volume | |
| Avg. Volume | 1,312,316 |
| Market Cap | 953.035M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 |
| Earnings Date | Oct 31, 2024 - Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.83 |
ZacksDo Options Traders Know Something About Aurinia (AUPH) Stock We Don't?
Investors need to pay close attention to Aurinia (AUPH) stock based on the movements in the options market lately.
Simply Wall St.Aurinia Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
Aurinia Pharmaceuticals ( NASDAQ:AUPH ) Second Quarter 2024 Results Key Financial Results Revenue: US$57.2m (up 38...
ZacksAurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of 100% and 4.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
? 2024 Yahoo. All rights reserved.